Sapphire Biotech Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Sapphire Biotech General Information

Description

Provider of research and development services to improve global cancer care, headquartered in San Diego, California. The company offers develops proprietary therapeutics for inhibiting cancer growth and metastasis as well as a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.

Contact Information

Website
www.sapphirebiotech.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 6197 Cornerstone Court East
  • Suite 103
  • San Diego, CA 92121
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
AXIM Biotechnologies
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6197 Cornerstone Court East
  • Suite 103
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sapphire Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sapphire Biotech‘s full profile, request access.

Request a free trial

Sapphire Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of research and development services to improve global cancer care, headquartered in San Diego, California. The
Diagnostic Equipment
San Diego, CA

Seattle, WA
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sapphire Biotech Competitors (18)

One of Sapphire Biotech’s 18 competitors is RareCyte, a Venture Capital-Backed company based in Seattle, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RareCyte Venture Capital-Backed Seattle, WA
Agendia Venture Capital-Backed Irvine, CA
Foundation Medicine Formerly VC-backed Boston, MA
Guardant Health Formerly VC-backed Palo Alto, CA
Asuragen Formerly VC-backed Austin, TX
You’re viewing 5 of 18 competitors. Get the full list »

Sapphire Biotech Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Sapphire Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023154292-A1 Sample collection devices, test kits, systems and methods Inactive 08-Feb-2022
WO-2023141305-A2 Assays, test kits and methods for detection of lacritin Inactive 20-Jan-2022
WO-2023141305-A3 Assays, test kits and methods for detection of lacritin Inactive 20-Jan-2022
US-20230251256-A1 Molecules, and related assays, test kits and methods Inactive 06-Oct-2021
WO-2023060210-A1 Molecules, and related assays, test kits and methods Inactive 06-Oct-2021 G01N33/54387
To view Sapphire Biotech’s complete patent history, request access »

Sapphire Biotech FAQs

  • Where is Sapphire Biotech headquartered?

    Sapphire Biotech is headquartered in San Diego, CA.

  • What industry is Sapphire Biotech in?

    Sapphire Biotech’s primary industry is Diagnostic Equipment.

  • Is Sapphire Biotech a private or public company?

    Sapphire Biotech is a Private company.

  • What is the current valuation of Sapphire Biotech?

    The current valuation of Sapphire Biotech is .

  • What is Sapphire Biotech’s current revenue?

    The current revenue for Sapphire Biotech is .

  • Who are Sapphire Biotech’s competitors?

    RareCyte, Agendia, Foundation Medicine, Guardant Health, and Asuragen are some of the 18 competitors of Sapphire Biotech.

  • When was Sapphire Biotech acquired?

    Sapphire Biotech was acquired on 17-Mar-2020.

  • Who acquired Sapphire Biotech?

    Sapphire Biotech was acquired by AXIM Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process